Sofinnova Partners SAS 4
4 · CinCor Pharma, Inc. · Filed Aug 17, 2022
Insider Transaction Report
Form 4
Sofinnova Partners SAS
10% Owner
Transactions
- Purchase
Common Stock
2022-08-15$30.00/sh+133,333$3,999,990→ 4,220,979 total(indirect: By Sofinnova Capital IX)
Footnotes (1)
- [F1]The shares are directly held by Sofinnova Capital IX ("SC IX"). Sofinnova Partners SAS ("Sofinnova Partners") is the management company of SC IX and may be deemed to share voting and investment power over the shares held by SC IX. Sofinnova Partners disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein.